The Institute for Follicular Lymphoma Innovation (IFLI)
Investor profile
Venture capital
The Institute for Follicular Lymphoma Innovation (IFLI) has backed 1 European tech company across 1 funding round in 2025, joining rounds totalling €16M. Most active in Healthtech. Data as of Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2025
1 yr
Total round €
€16M
sum of rounds joined
Deals by year
distinct rounds / yearThe Institute for Follicular Lymphoma Innovation (IFLI) — deals by year — interactive chart.
Data table
| The Institute for Follicular Lymphoma Innovation (IFLI) — deals by year | |
|---|---|
| 2025 | 1 |
Top sectors
by dealsThe Institute for Follicular Lymphoma Innovation (IFLI) — top sectors — interactive chart.
Data table
| The Institute for Follicular Lymphoma Innovation (IFLI) — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsThe Institute for Follicular Lymphoma Innovation (IFLI) — stages — interactive chart.
Data table
| The Institute for Follicular Lymphoma Innovation (IFLI) — stages | |
|---|---|
| Other | 1 |
Countries
by dealsThe Institute for Follicular Lymphoma Innovation (IFLI) — countries — interactive chart.
Data table
| The Institute for Follicular Lymphoma Innovation (IFLI) — countries | |
|---|---|
| France | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Enterome | France | 1 | €16M |